Viewing Study NCT03314935

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2026-03-06 @ 10:11 PM
Study NCT ID: NCT03314935
Status: COMPLETED
Last Update Posted: 2025-08-12
First Post: 2017-10-16
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Sponsor: Incyte Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer (BTC) View
None Colorectal Cancer (CRC) View
None Endometrial Cancer View
None Gastroesophageal Cancer (GC) View
None Ovarian Cancer View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None INCB001158 View
None arginase inhibitor View
None oxaliplatin View
None leucovorin View
None 5 fluorouracil View
None gemcitabine View
None cisplatin View
None paclitaxel View
None solid tumors View
None colorectal cancer View
None biliary tract cancer View
None gastroesophageal cancer View
None endometrial cancer View
None ovarian cancer View